AI assistant
Edwards Lifesciences Corp — Director's Dealing 2021
Dec 21, 2021
30042_dirs_2021-12-20_7874d85b-a4cd-4b73-be99-8bfb1a154d2e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-12-20
Reporting Person: MUSSALLEM MICHAEL A (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-20 | Common Stock | M | 45050.0000 | $21.7600 | Acquired | 233051.8200 | Direct |
| 2021-12-20 | Common Stock | S | 6526.0000 | $120.0900 | Disposed | 226525.8200 | Direct |
| 2021-12-20 | Common Stock | G | 12500.0000 | $0.0000 | Disposed | 214025.8200 | Direct |
| 2021-12-20 | Common Stock | S | 12809.0000 | $118.3700 | Disposed | 201216.8200 | Direct |
| 2021-12-20 | Common Stock | S | 13215.0000 | $119.3700 | Disposed | 188001.8200 | Direct |
| 2021-12-20 | Common Stock | G | 12500.0000 | $0.0000 | Acquired | 3235287.0000 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-20 | Employee Stock Option (Right to Acquire) | $21.7600 | M | 45050.0000 | Disposed | 2022-05-13 | Common Stock (45050.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 371719.8028 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.
F2: This transaction was executed in multiple trades at prices ranging from $119.8900 to $120.8200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $117.8700 to $118.8700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $118.8850 to $119.8550. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.